Mulsevo
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Mulsevo, covering 2012-07-09 to 2012-07-20. Get the full timeline:
Most recent: EMA Application withdrawn: Mulsevo (semuloparin sodium) — Sanofi-aventis groupe